CITANEST PLAIN Drug Patent Profile
✉ Email this page to a colleague
When do Citanest Plain patents expire, and when can generic versions of Citanest Plain launch?
Citanest Plain is a drug marketed by Astrazeneca and Dentsply Pharm and is included in two NDAs.
The generic ingredient in CITANEST PLAIN is prilocaine hydrochloride. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the prilocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Citanest Plain
A generic version of CITANEST PLAIN was approved as prilocaine hydrochloride by SEPTODONT INC on September 29th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CITANEST PLAIN?
- What are the global sales for CITANEST PLAIN?
- What is Average Wholesale Price for CITANEST PLAIN?
Summary for CITANEST PLAIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 123 |
| Clinical Trials: | 2 |
| Patent Applications: | 247 |
| DailyMed Link: | CITANEST PLAIN at DailyMed |
Recent Clinical Trials for CITANEST PLAIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bozyaka Training and Research Hospital | Phase 4 |
| Diskapi Teaching and Research Hospital | Phase 4 |
US Patents and Regulatory Information for CITANEST PLAIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | CITANEST PLAIN | prilocaine hydrochloride | INJECTABLE;INJECTION | 014763-007 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dentsply Pharm | CITANEST PLAIN DENTAL | prilocaine hydrochloride | INJECTABLE;INJECTION | 021382-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
